Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease

Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease

Abstract Background Osteoprotegerin (OPG) and osteopontin (OPN) are vascular calcification inhibitors with a known role in the atherosclerotic and inflammatory process. We investigated their relationship with adverse outcomes (restenosis/adverse cardiovascular events) after endovascular revascularis...

Full description

Bibliographic Details
Main Authors: Nikolaos P. E. Kadoglou, Dimitrios Kapetanios, Emmanouil Korakas, Georgia Valsami, Nikolaos Tentolouris, Nikolaos Papanas, Vaia Lambadiari, Christos Karkos
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Cardiovascular Diabetology
Subjects:
Osteoprotegerin
Osteopontin
Peripheral artery disease
MACE
Inflammation
Online Access:https://doi.org/10.1186/s12933-022-01605-6

Internet

https://doi.org/10.1186/s12933-022-01605-6

Similar Items